Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.390
+0.010 (0.72%)
Feb 21, 2025, 4:00 PM EST - Market closed
ABOS's stock price has decreased by -58.13% in the past year and price targets may not have had time to catch up.
Acumen Pharmaceuticals Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$9.33
Upside
+571.22%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +979.14% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +979.14% | Oct 3, 2024 |
| UBS | UBS | Strong Buy Maintains $14 → $6 | Strong Buy | Maintains | $14 → $6 | +331.65% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +979.14% | Aug 14, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +403.60% | Jul 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +979.14% | May 15, 2024 |
| UBS | UBS | Strong Buy Maintains $15 → $14 | Strong Buy | Maintains | $15 → $14 | +907.19% | Mar 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +979.14% | Mar 27, 2024 |
| Deutsche Bank | Deutsche Bank | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +475.54% | Dec 12, 2023 |
| Credit Suisse | Credit Suisse | Buy Reiterates $13 | Buy | Reiterates | $13 | +835.25% | Aug 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +979.14% | Aug 9, 2023 |
| B of A Securities | B of A Securities | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +907.19% | Jul 20, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $13 | Buy | Reiterates | $13 | +835.25% | Jul 17, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +979.14% | Jul 17, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $13 | Buy | Initiates | $13 | +835.25% | May 18, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $16 → $13 | Buy | Maintains | $16 → $13 | +835.25% | Mar 28, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.